Placental specific mRNA in the maternal circulation are globally dysregulated in pregnancies complicated by fetal growth restriction

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 3, 2013, Pages

  Whitehead, Clare L ^a,b   Walker, Susan P ^b   Ye, Louie ^a   Mendis, Sonali ^b   Kaitu'u Lino, Tu'uhevaha J ^a   Lappas, Martha ^b   Tong, Stephen ^a  

^a MERCY HOSPITAL FOR WOMEN   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; METASTIN;

ADULT; ARTICLE; CIRCULATION; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ANALYSIS; CONTROLLED STUDY; CRH GENE; CSH1 GENE; DISEASE SEVERITY; ERVWE 1 GENE; FEMALE; FETUS; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; HUMAN; IN SITU HYBRIDIZATION; INTRAUTERINE GROWTH RETARDATION; KISS1 GENE; MATERNAL BLOOD; MATERNAL CIRCULATION; MICROARRAY ANALYSIS; PAPPA2 GENE; PLAC3 GENE; PLACENTA; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; PSG1 GENE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SYNCYTIOTROPHOBLAST; TAC3 GENE; TRANSCRIPTOMICS;

ADULT; CORTICOTROPIN-RELEASING HORMONE; FEMALE; FETAL GROWTH RETARDATION; GENE PRODUCTS, ENV; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; KISSPEPTINS; PLACENTA; PLACENTAL LACTOGEN; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PREGNANCY-SPECIFIC BETA 1-GLYCOPROTEINS; RECEPTORS, TACHYKININ; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84874893549     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2468     Document Type: Article

References (33)

1. Marsal K. Obstetric management of intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol. 2009;23:857-870.
2. Smith GC, Fretts RC. Still birth. Lancet. 2007;370:1715-1725.
3. Froen JF, Gardosi JO, Thurmann A, Francis A, Stray-Pedersen B. Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand. 2004;83:801-807. (Pubitemid 39179434)
4. Ounsted M, Moar V, Scott WA. Perinatal morbidity and mortality in small-for-dates babies: the relative importance of some maternal factors. Early Hum Dev. 1981;5:367-375. (Pubitemid 11014499)
5. Flenady V, Middleton P, Smith GC, et al. Stillbirths: thewayforward in high-income countries. Lancet. 2011;377:1703-1717.
6. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485-487. (Pubitemid 27343304)
7. Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin Chem. 2000;46:1832-1834.
8. Tsui NB, Chim SS, Chiu RW, et al. Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J Med Genet. 2004;41:461-467. (Pubitemid 38788044)
9. Go AT, van Vugt JM, Oudejans CB. Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities. Hum Reprod Update. 2011;17:372-382.
10. ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002:99:159-167.
11. Paiva P, Whitehead C, Saglam B, Palmer K, Tong S. Measurement of mRNA transcripts of very high placental expression in maternal blood as biomarkers of preeclampsia. J Clin Endocrinol Metab. 2011;96:E1807-E1815.
12. Gourvas V, Dalpa E, Konstantinidou A, Vrachnis N, Spandidos DA, Sifakis S. Angiogenic factors in placentas from pregnancies complicatedby fetal growth restriction (review). Mol Med Report. 2012;6:23-27.
13. Baschat AA. Fetal growth restriction-from observation to intervention. J Perinat Med. 2010;38:239-246.
14. Brosens I, Dixon HG, Robertson WB. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol. 1977;84:656-663.
15. Smith SC, Baker PN, Symonds EM. Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol. 1997;177:57-65. (Pubitemid 27327311)
16. Kumpel B, King MJ, Sooranna S, Jackson D, Eastlake J, Cheng R, Johnson M. Phenotype and mRNA expression of syncytiotrophoblast microparticles isolated from human placenta. Ann NY Acad Sci. 2008;1137:144-147.
17. Rajakumar A, Cerdeira AS, Rana S, et al. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension. 2012;59:256-264.
18. Frendo JL, Olivier D, Cheynet V, et al. Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol Cell Biol. 2003;23:3566-3574. (Pubitemid 36539189)
19. Ruebner M, Strissel PL, Langbein M, et al. Impaired cell fusion and differentiation in placentae from patients with intrauterine growth restriction correlate with reduced levels of HERV envelope genes. J Mol Med (Berl). 2010;88:1143-1156.
20. Lo YM, Tsui NB, Chiu RW, et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med. 2007;13:218-223.
21. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab. 2002;87:1762-1767. (Pubitemid 34615266)
22. Yan X, Baxter RC, Firth SM. Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein- 5 proteolysis during pregnancy: a potential mechanism for increasing IGF bioavailability. J Clin Endocrinol Metab.2010;95:1412-1420.
23. Wang J, Qiu Q, Haider M, Bell M, Gruslin A, Christians JK. Expression of pregnancy-associated plasma protein A2 during pregnancy in human and mouse. J Endocrinol. 2009;202:337-345.
24. Mead EJ, Maguire JJ, Kuc RE, Davenport AP. Kisspeptins are novel potent vasoconstrictors in humans, with a discrete localization of their receptor, G protein-coupled receptor 54, to atherosclerosisprone vessels. Endocrinology. 2007;148:140-147. (Pubitemid 46021446)
25. Struwe E, Berzl G, Schild R, et al. Microarray analysis of placental tissue in intrauterine growth restriction. Clin Endocrinol (Oxf). 2010;72:241-247.
26. Wadhwa PD, Garite TJ, Porto M, et al. Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation. Am J Obstet Gynecol. 2004;191:1063-1069. (Pubitemid 39421552)
27. Horne CH, Towler CM, Jandial V. Pregnancy-specific β1-glycoprotein in early pregnancy. Lancet. 1977;1:707-708.
28. Gordon YB, Grudzinskas JG, Lewis JD, Jeffrey D, Letchworth AT. Circulating levels of pregnancy-specificβ1-glycoprotein and human placental lactogen in the third trimester of pregnancy: their relationship to parity, birth weight, and placental weight. Br J Obstet Gynaecol. 1977;84:642-647. (Pubitemid 8185915)
29. Mannik J, Vaas P, Rull K, Teesalu P, Rebane T, Laan M. Differential expression profile of growth hormone/chorionic somatomammotropin genes in placenta of small- and large-for-gestational-age newborns. J Clin Endocrinol Metab. 2010;95:2433-2442.
30. Pang WW, Tsui MH, Sahota D, et al. A strategy for identifying circulating placental RNA markers for fetal growth assessment. Prenat Diagn. 2009;29:495-504.
31. Armstrong RA, Reynolds RM, Leask R, Shearing CH, Calder AA, Riley SC. Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia. Prenat Diagn. 2009;29:982-985.
32. Smets EM, Deurloo KL, Go AT, van Vugt JM, Blankenstein MA, Oudejans CB. Decreased plasma levels of metastin in early pregnancy are associated with small for gestational age neonates. Prenat Diagn. 2008;28:299-303. (Pubitemid 351519066)
33. Page NM, Woods RJ, Gardiner SM, et al. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature. 2000;405:797-800. (Pubitemid 30407852)